From AOP-Wiki
Jump to: navigation, search


This is a legacy representation of this AOP. Please see the current version here:

AOP Title

Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)
Short name: Dopaminergic activity- endometrial carcinoma


Cancer AOP group. National Health and Environmental Effects Research Laboratory, Office of Research and Development, Integrated Systems Toxicology Division, US Environmental Protection Agency, Research Triangle Park, NC. Corresponding author for wiki entry (


Please follow the link to snapshots page to view and create Snapshots of this AOP.

OECD Project 1.29: A catalog of putative AOPs that will enhance the utility of US EPA Toxcast high throughput screening data for hazard identification

Under development: Do not distribute or cite.

This AOP page was last modified on 12/11/2016.

Click here to show/hide revision dates for related pages

Page Revision Date/Time


This putative adverse outcome pathway (AOP) outlines potential key events leading to a tumor outcome in standard carcinogenicity models. This information is based largely on modes of action described previously in cited literature sources and is intended as a resource template for AOP development and data organization. Presentation in this Wiki does not indicate EPA acceptance of a particular pathway for a given reference agent, only that the information has been proposed in some manner. In addition, this putative AOP relates to the model species indicated and does not directly address issues of human relevance.

Background (optional)

Summary of the AOP

Please follow link to widget page to edit this section.

If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.

Molecular Initiating Event

Molecular Initiating Event Support for Essentiality
Dopaminergic activity, Increase

Key Events

Event Support for Essentiality
Prolactin, Decreased
Estrogen receptor (ER) activity, Increased
Progesterone from corpus luteum, Decreased
Hyperplasia (glandular epithelial cells of endometrium), Increase

Adverse Outcome

Adverse Outcome
Endometrial adenocarcinomas, Increase

Relationships Among Key Events and the Adverse Outcome

Event Description Triggers Weight of Evidence Quantitative Understanding
Dopaminergic activity, Increase Directly Leads to Prolactin, Decreased
Prolactin, Decreased Directly Leads to Estrogen receptor (ER) activity, Increased
Estrogen receptor (ER) activity, Increased Directly Leads to Progesterone from corpus luteum, Decreased
Progesterone from corpus luteum, Decreased Directly Leads to Hyperplasia (glandular epithelial cells of endometrium), Increase
Hyperplasia (glandular epithelial cells of endometrium), Increase Directly Leads to Endometrial adenocarcinomas, Increase

Network View

   Cytoscape Web will replace the contents of this div with your graph.

Click nodes or edges.

Life Stage Applicability

Life Stage Evidence Links

Taxonomic Applicability

Name Scientific Name Evidence Links
Rattus norvegicus Rattus norvegicus NCBI

Sex Applicability

Sex Evidence Links

Graphical Representation

Click to upload graphical representation

Overall Assessment of the AOP

Domain of Applicability

Life Stage Applicability, Taxonomic Applicability, Sex Applicability
Elaborate on the domains of applicability listed in the summary section above. Specifically, provide the literature supporting, or excluding, certain domains.

Essentiality of the Key Events

Molecular Initiating Event Summary, Key Event Summary
Provide an overall assessment of the essentiality for the key events in the AOP. Support calls for individual key events can be included in the molecular initiating event, key event, and adverse outcome tables above.

Weight of Evidence Summary

Summary Table
Provide an overall summary of the weight of evidence based on the evaluations of the individual linkages from the Key Event Relationship pages.

Quantitative Considerations

Summary Table
Provide an overall discussion of the quantitative information available for this AOP. Support calls for the individual relationships can be included in the Key Event Relationship table above.

Considerations for Potential Applications of the AOP (optional)


Gunin, A. G., Emelianov, V., Tolmachev, A. S., & Tolmacheva, A. (2002). Effect of prolactin and dopaminergic drugs on uterine response to chronic estrogen exposure. J Endocrinol, 172(1), 61-69.

Harleman, J. H., Hargreaves, A., Andersson, H., & Kirk, S. (2012). A review of the incidence and coincidence of uterine and mammary tumors in Wistar and Sprague-Dawley rats based on the RITA database and the role of prolactin. Toxicol Pathol, 40(6), 926-930. doi: 10.1177/0192623312444621

O'Connor, J. C., Plowchalk, D. R., Van Pelt, C. S., Davis, L. G., & Cook, J. C. (2000). Role of prolactin in chloro-S-triazine rat mammary tumorigenesis. Drug Chem Toxicol, 23(4), 575-601. doi: 10.1081/DCT-100101972